Fosaprepitant Injection, Powder, Lyophilized, For Solution
Product Images NDC 68001-523

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fosaprepitant (NDC 68001-523). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Fosaprepinjcarton)

This is a product label for Fosaprepitant for injection, containing instructions regarding its preparation, usage, dosage, storage, expiry, and color codes. The label also includes the manufacturing and contact information of the product as well as the relevant National Drug Code (NDC) and Lot and Expiration dates. The label contains a warning that the solution should not be used with solutions containing divalent cations (e.g., Ca™, Mg™), including Lactated Ringer's solution and Hartmann's solution.*

FDA Label Image

Label (Fosaprepinjlabel)

FDA Label Image

Structure.jpg (Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.